Company Filing History:
Years Active: 2013-2025
Title: The Innovative Contributions of Sayaka Hori
Introduction
Sayaka Hori is a distinguished inventor based in Tokyo, Japan, known for her groundbreaking research in antibody development. With two patents to her name, Hori’s work has significantly advanced the field of therapeutics, particularly in addressing diseases related to CD4-expressing cells.
Latest Patents
One of Hori’s notable inventions is an anti-CD4 antibody that demonstrates a high affinity for CD4 and exhibits remarkable effector activities, such as antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cellular cytotoxicity (CDC). This innovative antibody binds to the extracellular region of CD4, making it a robust candidate for therapeutic and diagnostic applications. The patent includes a comprehensive process for producing this antibody or its fragments, utilizing hybridoma technology and DNA encoding, which marks a significant step forward in antibody engineering.
Career Highlights
Hori is associated with Kyowa Hakko Kirin Co., Limited, where she leverages her expertise to contribute to pioneering health solutions. Her research work has not only enhanced the understanding of CD4-expressing cell diseases but also paved the way for the development of targeted therapies.
Collaborations
Throughout her career, Sayaka Hori has collaborated with other talented individuals, including her coworkers Tomoaki Nakagawa and Rinpei Niwa. Together, they have combined their efforts to further advance the field and explore new dimensions in therapeutic innovations.
Conclusion
Sayaka Hori’s patents and contributions reflect her commitment to improving healthcare through innovation. By developing sophisticated antibodies that target specific diseases, she has positioned herself as a prominent figure in the scientific community. Her work not only exemplifies the spirit of innovation but also brings hope for effective treatment options in CD4-related conditions.